BridgeMD
New treatment option for Acute Kidney Injury
Official title Ultra-Low Contrast Angiography in AKI
ClinicalTrials.gov ID: NCT05906758
What this study is testing
- What it's testing
- The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Hospitalized patients who have AKI at admission or who develop AKI during admission and require invasive coronary angiography will be included in the...
You likely can't join if
- Stabilized renal function manifested by unchanged or downtrending serum creatinine during a 24-hour period prior to enrollment.
- Contraindication for invasive coronary angiography other than AKI.
- Percutaneous coronary intervention is indicated and cannot be postponed by 7 days.
- Need for renal replacement therapy before coronary angiography or planned renal replacement therapy after coronary angiography (if premeditated...
- Administration of intravascular contrast media during 7 days prior to the coronary angiography or within 6 days after coronary angiography.
- Pregnant patients, prisoners, cognitively impaired people, age below 18 years, unable or unwilling to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- New Orleans, Louisiana, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Orleans, Louisiana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.